Parkinson's disease/Site map
(Redirected from PD Site map)
Each line in the hierarchical Site Map below is in two parts:
- The link text as it usually appears in the text and
- The link to the page or subpage with its full Wikiversity name.
The User Guide for this Wikiversity learning project is at PD_Wiki_User_Guide
[edit | edit source]The Science Behind Parkinson's - Portal:The_Science_Behind_Parkinson's
[edit | edit source]- > Project Development - Portal:The_Science_Behind_Parkinson's/Project_Development
- > The six purposes of Section 1 - Portal:The_Science_Behind_Parkinson's/Section 1/more
> Section 1: Progress and Prospects in Parkinson's Research - Progress_and_Prospects_in_Parkinson's_Research
[edit | edit source]> > - Magazine Section - PD_Magazine_Section
[edit | edit source]- > Getting the ball rolling - PD_Magazine_Section/Getting_the_ball_rolling
- > Hot Topics - PD_Hot_Topics
- > Vitamin D - Deficiencies_as_PD_cause/Vitamin_D
- > Role of alpha-synuclein in pathogenesis - Current_Parkinson's_Paradigm/Role_of_alpha-synuclein
- > Neuroprotective agents - PD_Neuroprotection/Neuroprotective_agents
- > Biomarkers and Biomeasures - Monitoring_Parkinson's_Disease
- > Induced Pluripotent Stem Cells - Modelling_PD/iPSC
- > Genome-Wide Association Studies - PD_Inheritance/GWAS
- > Getting Drugs from Lab to Clinic - PD_Research_to_clinic
> > - Researching Parkinson's - Researching_Parkinson's
[edit | edit source]- > Modelling Parkinson's - Modelling_PD
- > Animal Models - Modelling_PD/Animal_Models
- > Rotenone Model - Modelling_PD/Rotenone PD Model
- > Induced Pluripotent Stem Cells - Modelling_PD/iPSC
- > Hot Topics - PD_Hot_Topics
- > Vitamin D - Deficiencies_as_PD_cause/Vitamin_D
- > Role of alpha-synuclein in pathogenesis - Current_Parkinson's_Paradigm/Role_of_alpha-synuclein
- > Neuroprotective agents - PD_Neuroprotection/Neuroprotective_agents
- > Biomarkers and Biomeasures - Monitoring_Parkinson's_Disease
- > Induced Pluripotent Stem Cells - Modelling_PD/iPSC
- > Genome-Wide Association Studies - PD_Inheritance/GWAS
- > Getting Drugs from Lab to Clinic - PD_Research_to_clinic
- > Modelling Parkinson's - Modelling_PD
> > - Causes - PD_Causes
[edit | edit source]- > Inheritance - PD_Inheritance
- > SNCA - PD_Inheritance/SNCA
- > LRRK2 - PD_Inheritance/LRRK2
- > MAPT - PD_Inheritance/MAPT
- > GBA - PD_Inheritance/GBA
- > HLA - PD_Inheritance/HLA
- > Trauma - Trauma as PD Cause
- > Infection - Infection_as_PD_cause
- > Melanoma - Infection_as_PD_cause/Melanoma
- > Whooping cough - Infection_as_PD_cause/Whooping cough
- > Helicobacter - Infection_as_PD_cause/Helicobacter_pylorii
- > Deficiencies
- > Blood - Deficiencies_as_PD_cause/Blood
- > Glutathione - Deficiencies_as_PD_cause/Glutathione
- > Melatonin - Deficiencies_as_PD_cause/Melatonin
- > Norepinephrine - Deficiencies_as_PD_cause/Norepinephrine
- > Vitamin D - Deficiencies_as_PD_cause/Vitamin_D
- > Zinc - Deficiencies_as_PD_cause/Zinc
- > Toxins - Toxins_as_PD_cause
- > Cadmium - Toxins_as_PD_cause/Cadmium
- > Copper - Toxins_as_PD_cause/Copper
- > Dieldrin - Toxins_as_PD_cause/Dieldrin
- > Manganese - Toxins_as_PD_cause/Manganese
- > Maneb - Toxins_as_PD_cause/Maneb
- > Mercury - Toxins_as_PD_cause/Mercury
- > MPTP - Toxins_as_PD_cause/MPTP
- > n-Hexane - Toxins_as_PD_cause/n-Hexane
- > Paraquat - Toxins_as_PD_cause/Paraquat
- > Rotenone - Toxins_as_PD_cause/Rotenone
- > Toluene - Toxins_as_PD_cause/Toluene
- > Trichloroethylene - Toxins_as_PD_cause/Trichloroethylene
- > Ziram - Toxins_as_PD_cause/Ziram
- > Inheritance - PD_Inheritance
> > - Pathogenesis - Parkinson's_Pathogenesis
[edit | edit source]- > Current Parkinson's Paradigm - Current_Parkinson's_Paradigm
- > Working Hypothesis - Current_Parkinson's_Paradigm/Working_Hypothesis
- > Emerging Hypotheses - Current_Parkinson's_Paradigm/Emerging_Hypotheses
- > Oxidative Stress - Current_Parkinson's_Paradigm/Oxidative_Stress
- > Role of alpha-synuclein - Current_Parkinson's_Paradigm/Role_of_alpha-synuclein
- > Current Parkinson's Paradigm - Current_Parkinson's_Paradigm
> > - Therapy - PD_Therapy
[edit | edit source]- > Transplantation - Transplantation_for_PD
- > Symptomatic Relief - Symptomatic Relief_for_PD
- > Bradykinesia - Symptomatic Relief_for_PD/Bradykinesia
- > Dyskinesia - Symptomatic Relief_for_PD/Dyskinesia
- > Festination - Symptomatic Relief_for_PD/Festination
- > Freezing - Symptomatic Relief_for_PD/Akinesia
- > Non-motor symptoms - Symptomatic Relief_for_PD/Non-Motor
- > Tremor - Symptomatic Relief_for_PD/Tremor
- > Exercise - Exercise_for_PD
- > Effect on symptoms - Exercise_for_PD/Effect_on_Symptoms ::::> Neuroprotective effects - Exercise_for_PD/Neuroprotective_effects
- > Neuroprotection - PD_Neuroprotection
- > Neuroprotective agents - PD_Neuroprotection/Neuroprotective_agents
- > Caffeine - PD_Neuroprotection/Caffeine
- > Celastrol - PD_Neuroprotection/Celastrol
- > Co-enzyme Q10 - PD_Neuroprotection/Co-Enzyme Q10
- > Creatine - PD_Neuroprotection/Creatine
- > DHA - PD_Neuroprotection/DHA
- > Exendin-4 (EX-4) - PD_Neuroprotection/Exendin-4 (EX-4)
- > GDNF - PD_Neuroprotection/GDNF
- > Glutathione (GSH) - PD_Neuroprotection/Glutathione (GSH)
- > GM1 - PD_Neuroprotection/GM1
- > Isradipine - PD_Neuroprotection/Isradipine
- > Melatonin - PD_Neuroprotection/Melatonin
- > Mirapex - PD_Neuroprotection/Mirapex
- > Minocycline - PD_Neuroprotection/Minocycline
- > Nicotine - PD_Neuroprotection/Nicotine
- > NSAIDs - PD_Neuroprotection/NSAIDs
- > Phenylbutyrate - PD_Neuroprotection/Phenylbutyrate
- > Phytic Acid - PD_Neuroprotection/Phytic Acid
- > Quinoxaline - PD_Neuroprotection/Quinoxaline
- > Rasagiline - PD_Neuroprotection/Rasagiline
- > Riboflavin - PD_Neuroprotection/Riboflavin
- > Statins - PD_Neuroprotection/Statins
- > Tolcapone - PD_Neuroprotection/Tolcapone
- > Urate & Uric Acid - PD_Neuroprotection/Urate & Uric Acid
- > Vitamin D - PD_Neuroprotection/Vitamin D
- > Vitamin E - PD_Neuroprotection/Vitamin E
- > From Lab to Clinic - PD_Research_to_clinic
- > Clinical trials and the route to market - PD_Research_to_clinic/The route to market
> > - Monitoring Disease - Monitoring_Parkinson's_Disease
[edit | edit source]- > Biomarkers - Biomarkers_for_PD
- > Measurement of Disease Progression - Measurement_of_Parkinson's_Disease Progression
> > - Atypical parkinsonism - Atypical_parkinsonism
[edit | edit source]- > MSA - Multiple_System_Atrophy
- > PSP - Progressive_Supranuclear_Palsy
- > DLB - Dementia_with_Lewy_Bodies
- > ET - Essential Tremor
- > CBD - Corticobasal_Degeneration_(CBD)
> Section 2: Introduction to Parkinson's Science - Introduction_to_Parkinson's_Science
[edit | edit source]- > Site Map for Section 2 - Introduction_to_Parkinson's_Science/Site_Map